List of Excipients in API cefuroxime axetil
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing cefuroxime axetil
Detailed excipient profiles for cefuroxime axetil
Excipient focus: ALUMINUM OXIDE
cefuroxime axetil drug variants containing ALUMINUM OXIDE
cefuroxime axetil drug variants not containing ALUMINUM OXIDE
Excipient focus: ASPARTAME
cefuroxime axetil drug variants containing ASPARTAME
| Company | Ingredient | NDC |
|---|---|---|
| Ranbaxy Pharmaceuticals Inc | cefuroxime axetil | 63304-963 |
| >Company | >Ingredient | >NDC |
cefuroxime axetil drug variants not containing ASPARTAME
Excipient focus: CALCIUM CARBONATE
cefuroxime axetil drug variants containing CALCIUM CARBONATE
cefuroxime axetil drug variants not containing CALCIUM CARBONATE
Excipient focus: CALCIUM STEARATE
cefuroxime axetil drug variants containing CALCIUM STEARATE
cefuroxime axetil drug variants not containing CALCIUM STEARATE
Excipient focus: CELLULOSE, MICROCRYSTALLINE
cefuroxime axetil drug variants containing CELLULOSE, MICROCRYSTALLINE
cefuroxime axetil drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| STAT Rx USA LLC | cefuroxime axetil | 16590-215 |
| PD-Rx Pharmaceuticals Inc | cefuroxime axetil | 55289-385 |
| Wockhardt Limited | cefuroxime axetil | 55648-920 |
| Ranbaxy Pharmaceuticals Inc | cefuroxime axetil | 63304-963 |
| >Company | >Ingredient | >NDC |
Excipient focus: COLLOIDAL SILICON DIOXIDE
cefuroxime axetil drug variants containing COLLOIDAL SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| HJ Harkins Company Inc | cefuroxime axetil | 52959-308 |
| >Company | >Ingredient | >NDC |
cefuroxime axetil drug variants not containing COLLOIDAL SILICON DIOXIDE
Excipient focus: CROSCARMELLOSE SODIUM
cefuroxime axetil drug variants containing CROSCARMELLOSE SODIUM
cefuroxime axetil drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Ranbaxy Pharmaceuticals Inc | cefuroxime axetil | 63304-963 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
cefuroxime axetil drug variants containing CROSPOVIDONE
cefuroxime axetil drug variants not containing CROSPOVIDONE
Excipient focus: D&C RED NO. 27
cefuroxime axetil drug variants containing D&C RED NO. 27
| Company | Ingredient | NDC |
|---|---|---|
| MedVantx Inc | cefuroxime axetil | 66116-479 |
| >Company | >Ingredient | >NDC |
cefuroxime axetil drug variants not containing D&C RED NO. 27
Excipient focus: DIBUTYL SEBACATE
cefuroxime axetil drug variants containing DIBUTYL SEBACATE
| Company | Ingredient | NDC |
|---|---|---|
| STAT Rx USA LLC | cefuroxime axetil | 16590-215 |
| PD-Rx Pharmaceuticals Inc | cefuroxime axetil | 55289-385 |
| Wockhardt Limited | cefuroxime axetil | 55648-920 |
| Wockhardt USA LLC | cefuroxime axetil | 64679-920 |
| >Company | >Ingredient | >NDC |
cefuroxime axetil drug variants not containing DIBUTYL SEBACATE
Excipient focus: FD&C BLUE NO. 1
cefuroxime axetil drug variants containing FD&C BLUE NO. 1
cefuroxime axetil drug variants not containing FD&C BLUE NO. 1
Excipient focus: HYDROGENATED CASTOR OIL
cefuroxime axetil drug variants containing HYDROGENATED CASTOR OIL
| Company | Ingredient | NDC |
|---|---|---|
| STAT Rx USA LLC | cefuroxime axetil | 16590-215 |
| PD-Rx Pharmaceuticals Inc | cefuroxime axetil | 55289-385 |
| Wockhardt Limited | cefuroxime axetil | 55648-920 |
| Wockhardt USA LLC | cefuroxime axetil | 64679-920 |
| >Company | >Ingredient | >NDC |
cefuroxime axetil drug variants not containing HYDROGENATED CASTOR OIL
Excipient focus: HYDROGENATED COTTONSEED OIL
cefuroxime axetil drug variants containing HYDROGENATED COTTONSEED OIL
cefuroxime axetil drug variants not containing HYDROGENATED COTTONSEED OIL
Excipient focus: HYPROMELLOSE
cefuroxime axetil drug variants containing HYPROMELLOSE
cefuroxime axetil drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2910
cefuroxime axetil drug variants containing HYPROMELLOSE 2910
cefuroxime axetil drug variants not containing HYPROMELLOSE 2910
Excipient focus: HYPROMELLOSE PHTHALATE
cefuroxime axetil drug variants containing HYPROMELLOSE PHTHALATE
| Company | Ingredient | NDC |
|---|---|---|
| Ranbaxy Pharmaceuticals Inc | cefuroxime axetil | 63304-963 |
| >Company | >Ingredient | >NDC |
cefuroxime axetil drug variants not containing HYPROMELLOSE PHTHALATE
Excipient focus: HYPROMELLOSES
cefuroxime axetil drug variants containing HYPROMELLOSES
cefuroxime axetil drug variants not containing HYPROMELLOSES
Excipient focus: MANNITOL
cefuroxime axetil drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Ranbaxy Pharmaceuticals Inc | cefuroxime axetil | 63304-963 |
| >Company | >Ingredient | >NDC |
cefuroxime axetil drug variants not containing MANNITOL
Excipient focus: METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER
cefuroxime axetil drug variants containing METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| Ranbaxy Pharmaceuticals Inc | cefuroxime axetil | 63304-963 |
| >Company | >Ingredient | >NDC |
cefuroxime axetil drug variants not containing METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER
Excipient focus: MONOSODIUM CITRATE
cefuroxime axetil drug variants containing MONOSODIUM CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| Ranbaxy Pharmaceuticals Inc | cefuroxime axetil | 63304-963 |
| >Company | >Ingredient | >NDC |
cefuroxime axetil drug variants not containing MONOSODIUM CITRATE
Excipient focus: POLYETHYLENE GLYCOL 400
cefuroxime axetil drug variants containing POLYETHYLENE GLYCOL 400
cefuroxime axetil drug variants not containing POLYETHYLENE GLYCOL 400
Excipient focus: POLYETHYLENE GLYCOL 4000
cefuroxime axetil drug variants containing POLYETHYLENE GLYCOL 4000
| Company | Ingredient | NDC |
|---|---|---|
| PD-Rx Pharmaceuticals Inc | cefuroxime axetil | 43063-584 |
| LUPIN LIMITED | cefuroxime axetil | 57297-302 |
| Golden State Medical Supply Inc | cefuroxime axetil | 60429-656 |
| Lupin Pharmaceuticals Inc | cefuroxime axetil | 68180-302 |
| >Company | >Ingredient | >NDC |
cefuroxime axetil drug variants not containing POLYETHYLENE GLYCOL 4000
Excipient focus: POLYSORBATE 80
cefuroxime axetil drug variants containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| STAT Rx USA LLC | cefuroxime axetil | 16590-215 |
| PD-Rx Pharmaceuticals Inc | cefuroxime axetil | 55289-385 |
| Wockhardt Limited | cefuroxime axetil | 55648-920 |
| Wockhardt USA LLC | cefuroxime axetil | 64679-920 |
| >Company | >Ingredient | >NDC |
cefuroxime axetil drug variants not containing POLYSORBATE 80
Excipient focus: PROPYLENE GLYCOL
cefuroxime axetil drug variants containing PROPYLENE GLYCOL
cefuroxime axetil drug variants not containing PROPYLENE GLYCOL
Excipient focus: SHELLAC
cefuroxime axetil drug variants containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| STAT Rx USA LLC | cefuroxime axetil | 16590-215 |
| PD-Rx Pharmaceuticals Inc | cefuroxime axetil | 55289-385 |
| Wockhardt Limited | cefuroxime axetil | 55648-920 |
| Wockhardt USA LLC | cefuroxime axetil | 64679-920 |
| >Company | >Ingredient | >NDC |
cefuroxime axetil drug variants not containing SHELLAC
Excipient focus: SILICON DIOXIDE
cefuroxime axetil drug variants containing SILICON DIOXIDE
cefuroxime axetil drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| HJ Harkins Company Inc | cefuroxime axetil | 52959-308 |
| >Company | >Ingredient | >NDC |
Excipient focus: SMCC
cefuroxime axetil drug variants containing SMCC
| Company | Ingredient | NDC |
|---|---|---|
| STAT Rx USA LLC | cefuroxime axetil | 16590-215 |
| PD-Rx Pharmaceuticals Inc | cefuroxime axetil | 55289-385 |
| Wockhardt Limited | cefuroxime axetil | 55648-920 |
| >Company | >Ingredient | >NDC |
cefuroxime axetil drug variants not containing SMCC
Excipient focus: SODIUM BENZOATE
cefuroxime axetil drug variants containing SODIUM BENZOATE
| Company | Ingredient | NDC |
|---|---|---|
| Ranbaxy Pharmaceuticals Inc | cefuroxime axetil | 63304-963 |
| >Company | >Ingredient | >NDC |
cefuroxime axetil drug variants not containing SODIUM BENZOATE
Excipient focus: SODIUM CHLORIDE
cefuroxime axetil drug variants containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Ranbaxy Pharmaceuticals Inc | cefuroxime axetil | 63304-963 |
| >Company | >Ingredient | >NDC |
cefuroxime axetil drug variants not containing SODIUM CHLORIDE
Excipient focus: SODIUM LAURYL SULFATE
cefuroxime axetil drug variants containing SODIUM LAURYL SULFATE
cefuroxime axetil drug variants not containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Ranbaxy Pharmaceuticals Inc | cefuroxime axetil | 63304-963 |
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
cefuroxime axetil drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| MedVantx Inc | cefuroxime axetil | 66116-479 |
| >Company | >Ingredient | >NDC |
cefuroxime axetil drug variants not containing STARCH, CORN
Excipient focus: SUCROSE
cefuroxime axetil drug variants containing SUCROSE
| Company | Ingredient | NDC |
|---|---|---|
| Ranbaxy Pharmaceuticals Inc | cefuroxime axetil | 63304-963 |
| >Company | >Ingredient | >NDC |
cefuroxime axetil drug variants not containing SUCROSE
Excipient focus: TALC
cefuroxime axetil drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| PD-Rx Pharmaceuticals Inc | cefuroxime axetil | 43063-584 |
| LUPIN LIMITED | cefuroxime axetil | 57297-302 |
| Golden State Medical Supply Inc | cefuroxime axetil | 60429-656 |
| Lupin Pharmaceuticals Inc | cefuroxime axetil | 68180-302 |
| >Company | >Ingredient | >NDC |
cefuroxime axetil drug variants not containing TALC
Excipient focus: TITANIUM DIOXIDE
cefuroxime axetil drug variants containing TITANIUM DIOXIDE
cefuroxime axetil drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | cefuroxime axetil | 21695-370 |
| HJ Harkins Company Inc | cefuroxime axetil | 52959-939 |
| Physicians Total Care Inc | cefuroxime axetil | 54868-4987 |
| DIRECT RX | cefuroxime axetil | 61919-044 |
| Ranbaxy Pharmaceuticals Inc | cefuroxime axetil | 63304-963 |
| >Company | >Ingredient | >NDC |
Excipient focus: XANTHAN GUM
cefuroxime axetil drug variants containing XANTHAN GUM
| Company | Ingredient | NDC |
|---|---|---|
| Ranbaxy Pharmaceuticals Inc | cefuroxime axetil | 63304-963 |
| >Company | >Ingredient | >NDC |
cefuroxime axetil drug variants not containing XANTHAN GUM
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
